Jennison Associates
GH icon

Jennison Associates’s Guardant Health GH Stock Holding History

Jennison Associates’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.4M Buy
356,001
+152,223
+75% +$16.6M 0.03% 226
2026
Q1 		$18.8M Sell
203,778
-966,559
-83% -$97M 0.01% 336
2025
Q4 		$120M Sell
1,170,337
-300,957
-20% -$26.9M 0.07% 117
2025
Q3 		$91.9M Buy
1,471,294
+755,827
+106% +$41.1M 0.05% 141
2025
Q2 		$37.2M Buy
+715,467
New +$32M 0.02% 258
2024
Q3 		– Sell
-497,088
Closed -$14.4M – 582
2024
Q2 		$14.4M Buy
497,088
+7,431
+2% +$173K 0.01% 359
2024
Q1 		$10.1M Buy
489,657
+9,811
+2% +$210K 0.01% 397
2023
Q4 		$13M Sell
479,846
-1,411,038
-75% -$37M 0.01% 364
2023
Q3 		$56M Buy
1,890,884
+403,475
+27% +$14.2M 0.05% 162
2023
Q2 		$53.2M Buy
+1,487,409
New +$42.7M 0.04% 182
2022
Q1 		– Sell
-167,226
Closed -$16.7M – 661
2021
Q4 		$16.7M Sell
167,226
-509,718
-75% -$52.7M 0.01% 392
2021
Q3 		$84.6M Sell
676,944
-8,175
-1% -$971K 0.05% 135
2021
Q2 		$85.1M Sell
685,119
-2,043,552
-75% -$275M 0.06% 144
2021
Q1 		$417M Sell
2,728,671
-278,306
-9% -$42.1M 0.3% 54
2020
Q4 		$388M Sell
3,006,977
-170,468
-5% -$19.6M 0.28% 55
2020
Q3 		$355M Sell
3,177,445
-157,764
-5% -$14.4M 0.29% 51
2020
Q2 		$271M Buy
3,335,209
+737,024
+28% +$59.4M 0.24% 53
2020
Q1 		$181M Sell
2,598,185
-64,048
-2% -$4.91M 0.22% 59
2019
Q4 		$208M Sell
2,662,233
-713,456
-21% -$51.4M 0.21% 64
2019
Q3 		$215M Buy
3,375,689
+622,154
+23% +$54.8M 0.23% 59
2019
Q2 		$238M Buy
2,753,535
+2,068,098
+302% +$158M 0.24% 58
2019
Q1 		$52.6M Sell
685,437
-157,883
-19% -$8.75M 0.05% 214
2018
Q4 		$31.7M Buy
+843,320
New +$31.1M 0.04% 274

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jennison Associates's GH Position: Q2 2026 in Review

Jennison Associates increased its Guardant Health (GH) stake by 75% in Q2 2026, buying an estimated $16.6M and bringing the position to 356,001 shares worth $53.4M. The position accounts for 0.03% of the portfolio, ranked #226.

Jennison Associates first reported a position in GH in Q4 2018 and has held it in 23 quarters since. The position peaked at $417M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Jennison Associates held 356,001 shares of Guardant Health worth $53.4M as of Q2 2026.
  • Jennison Associates bought 152,223 Guardant Health shares in Q2 2026, an estimated $16.6M.
  • Guardant Health made up 0.03% of Jennison Associates's portfolio in Q2 2026, its #226 holding.
  • Jennison Associates first reported a position in Guardant Health in Q4 2018 and has held it in 23 quarters since.
  • Jennison Associates's Guardant Health position peaked at $417M in Q1 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.